Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Gerry

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Circulation. Cardiovascular Interventions|October 5, 2019
Impact of Procedural Bleeding in Peripheral Artery Disease: An Analysis From EUCLID TrialAman Kansal, Zhen Huang, Frank W Rockhold, et al.
American Heart Journal|May 16, 2016
Design and rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) trialJeffrey S Berger, Brian G Katona, W Schuyler Jones, et al.
The New England Journal of Medicine|December 14, 2016
Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery DiseaseWilliam R Hiatt, F Gerry R Fowkes, Gretchen Heizer, et al.
Journal of the American Heart Association|May 27, 2022
Total Cardiovascular and Limb Events and the Impact of Polyvascular Disease in Chronic Symptomatic Peripheral Artery DiseaseMichael Szarek, Connie Hess, Manesh R Patel, et al.
Vascular Medicine (London, England)|September 13, 2021
World regional differences in outcomes for patients with peripheral artery disease: Insights from the EUCLID trialLars Norgren, Rebecca North, Iris Baumgartner, et al.
Circulation. Cardiovascular Interventions|October 12, 2020
Association of Disease Progression With Cardiovascular and Limb Outcomes in Patients With Peripheral Artery Disease: Insights From the EUCLID TrialJennifer A Rymer, Hillary Mulder, Dennis I Narcisse, et al.
JAMA Cardiology|December 13, 2018
Incidence, Characteristics, and Outcomes of Myocardial Infarction in Patients With Peripheral Artery Disease: Insights From the EUCLID TrialChristoph B Olivier, Hillary Mulder, William R Hiatt, et al.
Journal of the American Heart Association|September 14, 2020
Association of Health Status Scores With Cardiovascular and Limb Outcomes in Patients With Symptomatic Peripheral Artery Disease: Insights From the EUCLID (Examining Use of Ticagrelor in Symptomatic Peripheral Artery Disease) TrialJennifer A Rymer, Hillary Mulder, Kim G Smolderen, et al.
Circulation|June 27, 2019
Acute Limb Ischemia in Peripheral Artery DiseaseConnie N Hess, Zhen Huang, Manesh R Patel, et al.
Journal of the American College of Cardiology|February 15, 2020
Sex-Specific Risks of Major Cardiovascular and Limb Events in Patients With Symptomatic Peripheral Artery DiseaseAxel Haine, Sarah Kavanagh, Jeffrey S Berger, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Circulation. Cardiovascular Interventions|October 5, 2019
Impact of Procedural Bleeding in Peripheral Artery Disease: An Analysis From EUCLID TrialAman Kansal, Zhen Huang, Frank W Rockhold, et al.
American Heart Journal|May 16, 2016
Design and rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) trialJeffrey S Berger, Brian G Katona, W Schuyler Jones, et al.
The New England Journal of Medicine|December 14, 2016
Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery DiseaseWilliam R Hiatt, F Gerry R Fowkes, Gretchen Heizer, et al.
Journal of the American Heart Association|May 27, 2022
Total Cardiovascular and Limb Events and the Impact of Polyvascular Disease in Chronic Symptomatic Peripheral Artery DiseaseMichael Szarek, Connie Hess, Manesh R Patel, et al.
Vascular Medicine (London, England)|September 13, 2021
World regional differences in outcomes for patients with peripheral artery disease: Insights from the EUCLID trialLars Norgren, Rebecca North, Iris Baumgartner, et al.
Circulation. Cardiovascular Interventions|October 12, 2020
Association of Disease Progression With Cardiovascular and Limb Outcomes in Patients With Peripheral Artery Disease: Insights From the EUCLID TrialJennifer A Rymer, Hillary Mulder, Dennis I Narcisse, et al.
JAMA Cardiology|December 13, 2018
Incidence, Characteristics, and Outcomes of Myocardial Infarction in Patients With Peripheral Artery Disease: Insights From the EUCLID TrialChristoph B Olivier, Hillary Mulder, William R Hiatt, et al.
Journal of the American Heart Association|September 14, 2020
Association of Health Status Scores With Cardiovascular and Limb Outcomes in Patients With Symptomatic Peripheral Artery Disease: Insights From the EUCLID (Examining Use of Ticagrelor in Symptomatic Peripheral Artery Disease) TrialJennifer A Rymer, Hillary Mulder, Kim G Smolderen, et al.
Circulation|June 27, 2019
Acute Limb Ischemia in Peripheral Artery DiseaseConnie N Hess, Zhen Huang, Manesh R Patel, et al.
Journal of the American College of Cardiology|February 15, 2020
Sex-Specific Risks of Major Cardiovascular and Limb Events in Patients With Symptomatic Peripheral Artery DiseaseAxel Haine, Sarah Kavanagh, Jeffrey S Berger, et al.
Pageof 7